AUS
NZ
UK
CA
USA
IND
Healthcare
Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval for Striate+
March 18, 2025 05:08 PM AEDT| By Team Kalkine MediaHighlights,Singapore’s Health Sciences Authority grants approval for Striate+,Global sales growth continues with strong adoption rates,Expansion efforts underway with entry into new international markets,Orthocell (ASX:OCC) has secured regulatory app...
CLEO Diagnostics initiates the transfer of intellectual property for ovarian cancer blood tests to manufacturers in the US.
March 18, 2025 03:31 PM AEDT| By Team Kalkine MediaHighlights:,CLEO Diagnostics progresses with technology transfer for its ovarian cancer blood test.,Collaboration with R&D Systems Inc supports antibody development for commercial prototypes.,Negotiations continue for selecting FDA-registered manufac...
Would Next Science (NXS) Benefit from Reducing Its Debt?
March 18, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights:,Next Science reports a low net debt position with liquid assets nearly balancing liabilities.,The company’s revenue has grown, though operating losses remain a key factor in financial assessments.,A focus on balance sheet improvement cont...
Invex Therapeutics (ASX:IXC) - A Glimpse of Change
March 18, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights,Invex Therapeutics shares increased by 12% in a week,A significant decrease of 88% over three years,Total Shareholder Return (TSR) outperforms share price drop,Invex Therapeutics Ltd (,ASX:IXC,) has witnessed a 12% rise in its share price...
Chimeric Therapeutics (ASX:CHM) Launches $3.2M Entitlement Offer to Advance Cancer Trials
March 18, 2025 02:01 PM AEDT| By Team Kalkine MediaHighlights,Chimeric Therapeutics (CHM) announces a $3.2 million entitlement offer.,Funds to support ongoing clinical trials in neuroendocrine, colorectal, and blood cancers.,Eligible shareholders offered new shares at a 16.7% discount with,additional...
Major Developments in ASX Health and Biotech Firms
March 18, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Nanosonics receives FDA clearance for Coris, aimed at improving infection control in hospitals.,Imricor secures substantial funding for accelerating its cardiac device, aiming at revolutionizing heart procedures.,PolyNovo tackles managemen...
Medical Developments International (ASX:MVP) Sees Sharp Drop – What’s Behind It?
March 17, 2025 06:56 PM AEDT| By Team Kalkine MediaHighlights,Medical Developments International (MVP) has declined by 27% in the last month.,The stock's price-to-sales ratio is significantly lower than industry peers.,Revenue growth remains steady, but investor confidence seems uncertain.,Medical De...
Global Health (ASX:GLH) Expands Digital Healthcare with $1 Million Youturn Partnership
March 17, 2025 05:12 PM AEDT| By Team Kalkine MediaHighlights,Global Health (GLH) secures a $1 million contract with Youturn for digital health solutions.,The partnership aims to streamline operations across 12 healthcare organisations.,The deal includes innovative platforms to enhance service effici...
Is Ansell Limited (ASX:ANN) Facing Market Pressure Due to Financial Performance?
March 17, 2025 02:01 PM AEDT| By Team Kalkine MediaHighlights,Ansell Limited (ANN) has seen a 7.2% decline in stock value over the past month.,The company's return on equity (ROE) stands at 5.9%, below the industry average of 9.9%.,Analysts expect future earnings growth, with ROE predicted to rise to...
Ebos Group Dismisses Speculation on Real Pet Food Company Acquisition
March 17, 2025 12:55 PM AEDT| By Team Kalkine MediaHighlights,Ebos,Group (,ASX:EBO,) refutes reports of pursuing Real Pet Food Company.,Company,maintains,its focus on strategic, small-to-medium acquisitions.,Official statement clarifies that the reported deal is inaccurate.,Ebos Group (ASX:EBO), a le...
EMVision prepares for crucial stroke scanner trial this year
March 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,EMVision progresses from development to commercialization with portable brain scanners for stroke diagnosis.,A pivotal clinical trial supporting FDA approval of the emu bedside device is set to begin.,Collaboration with Keysight Technolog...
Neurizon Therapeutics Advances Pharmacokinetic Studies to Address FDA Hold
March 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,Neurizon submits a request to the FDA for clarification on pharmacokinetic studies to lift the clinical hold on NUZ-001.,The FDA is expected to respond within 60 days, as Neurizon proactively starts the studies.,The completion of these stud...
US FDA Approvals: A Crucial Step for ASX Biotech Companies
March 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,FDA approval remains pivotal for global drug and device companies seeking market entry into the profitable US healthcare market.,ASX biotech companies experience significant share price surges following successful FDA approvals, despite the...
Race initiates its first Phase I trial location for a cardioprotective anticancer drug candidate.
March 16, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Race Oncology commences Phase I trials of RC220 in New South Wales, marking progress in its oncology treatment strategy.,The study evaluates RC220 both alone and combined with doxorubicin to assess safety and treatment compatibility.,Inter...
Race receives ethical approval for Phase I trial in patients with solid tumors.
March 14, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Ethics approval secured for a Phase I trial of RC220 bisantrene targeting solid tumors.,Patient enrollment set to begin at Southside Cancer Care Centre, with trial expansion planned.,Study to assess safety, tolerability, and pharmacokinet...
Oakridge International Insider Trust Pays Off as Stock Reaches AU$1.9 Million Market Cap
March 13, 2025 05:31 PM AEDT| By Team Kalkine MediaHighlights,Recent share surge leads to significant gains for insiders.,Executive Chairman & CEO's substantial share purchase stands out.,Strong insider ownership aligns interests with shareholders.,Insiders at Oakridge International Limited (ASX:OAK)...
We're Eager to See How Mach7 Technologies Utilizes Its Cash Reserve for Growth
March 13, 2025 05:30 PM AEDT| By Team Kalkine MediaHighlights:,Mach7 Technologies maintains a strong financial position with a substantial cash reserve and no debt.,Revenue growth has been steady, demonstrating the company’s expanding business operations.,A low cash burn relative to market capitaliza...
Early Detection of Diabetic Kidney Disease Gets a Boost with PromarkerD Launch in Australia
March 13, 2025 02:14 PM AEDT| By Team Kalkine MediaHighlights,PromarkerD,launched in Australia for early diabetic kidney disease detection,Study shows,PromarkerD,outperforms standard tests in predicting kidney function decline,Engagement with stakeholders to expand accessibility and adoption,Proteomi...
Insider Confidence in Oakridge International Strengthens as Market Value Climbs
March 13, 2025 01:39 PM AEDT| By Team Kalkine MediaHighlights:,Oakridge International (,ASX:OAK,) sees an 11% stock surge, boosting market cap by AU$189k.,Insider purchases from the past year now reflect a 33% gain.,Executive,Chairman,& CEO’s AU$500k investment aligns leadership with shareholder inte...
TrivarX alerts to US Veterans Affairs mental health trial—then suspends trading for fundraising effort
March 13, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights:,TrivarX collaborates with the US Department of Veterans Affairs for a clinical trial focused on mental health diagnostics.,The trial will assess an advanced algorithm that analyzes heart rate data during sleep to identify depressive episo...
Advertise your brand on Kalkine Media